Therapeutic Depth: Infectious Disease

Wide-ranging Infectious Disease Expertise

Therapeutic Depth: Infectious Disease

Infectious diseases kill a child almost every three seconds. Every day 3,000 people die from malaria. 1.5 million people die each year from tuberculosis. In an era of vaccines and antibodies, infectious diseases that should be under control rage on in many developing countries.

Synteract has a breadth of experience managing infectious disease studies. With immunization estimated to avert between two to three million deaths each year, Synteract is committed to quality clinical development of vaccinations and supporting the study of infectious diseases in adult and pediatric populations the world over.

Synteract has successfully performed a diverse range of Phase I- IV studies, including:

  • Comparing and Characterizing (different parameters)
  • Dose Escalation
  • Dose-finding and Safety
  • Feasibility
  • Immunogenicity
  • Long-term Follow-up (antibodies)
  • Protective Efficacy
  • Safety Immunogenicity in Children and Adolescents
  • Tolerability

Synteract has expertise in:

  • Concomitant Administrations of Meningococcal and Pneumococcal
  • Conjugated Meningitis
  • Hepatitis A
  • Human Immunodeficiency Virus
  • Influenza
  • Rabies
  • Recombinant Hypoallergenic Grass Pollen
  • Smallpox Booster
  • Subcutaneous Immunotherapy
  • Tick-borne Encephalitis
x

Contact Synteract

Tell us how to stay in touch with you:

*Required